JP2004510683A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2004510683A5 JP2004510683A5 JP2001501263A JP2001501263A JP2004510683A5 JP 2004510683 A5 JP2004510683 A5 JP 2004510683A5 JP 2001501263 A JP2001501263 A JP 2001501263A JP 2001501263 A JP2001501263 A JP 2001501263A JP 2004510683 A5 JP2004510683 A5 JP 2004510683A5
- Authority
- JP
- Japan
- Prior art keywords
- antibody
- tumor
- radioimmunotherapy
- clarifier
- kit
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US13863599P | 1999-06-07 | 1999-06-07 | |
| PCT/US2000/015477 WO2000074729A2 (en) | 1999-06-07 | 2000-06-07 | Alpha or beta emitters to fragments in radioimmunotherapy |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2004510683A JP2004510683A (ja) | 2004-04-08 |
| JP2004510683A5 true JP2004510683A5 (cg-RX-API-DMAC7.html) | 2005-06-02 |
Family
ID=22482926
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2001501263A Pending JP2004510683A (ja) | 1999-06-07 | 2000-06-07 | 放射免疫療法において断片に付着されるα線エミッタまたはβ線エミッタ |
Country Status (6)
| Country | Link |
|---|---|
| US (2) | US6667024B1 (cg-RX-API-DMAC7.html) |
| EP (1) | EP1187637A2 (cg-RX-API-DMAC7.html) |
| JP (1) | JP2004510683A (cg-RX-API-DMAC7.html) |
| AU (1) | AU5727000A (cg-RX-API-DMAC7.html) |
| CA (1) | CA2374001A1 (cg-RX-API-DMAC7.html) |
| WO (1) | WO2000074729A2 (cg-RX-API-DMAC7.html) |
Families Citing this family (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6107090A (en) | 1996-05-06 | 2000-08-22 | Cornell Research Foundation, Inc. | Treatment and diagnosis of prostate cancer with antibodies to extracellur PSMA domains |
| US6136311A (en) | 1996-05-06 | 2000-10-24 | Cornell Research Foundation, Inc. | Treatment and diagnosis of cancer |
| CA2422291C (en) * | 2000-09-15 | 2011-03-08 | Sloan-Kettering Institute For Cancer Research | Targeted alpha particle therapy using actinium-225 conjugates |
| US7514078B2 (en) | 2001-06-01 | 2009-04-07 | Cornell Research Foundation, Inc. | Methods of treating prostate cancer with anti-prostate specific membrane antigen antibodies |
| CA2447695C (en) | 2001-06-01 | 2015-02-24 | Cornell Research Foundation, Inc. | Modified antibodies to prostate-specific membrane antigen and uses thereof |
| IL159422A0 (en) | 2001-09-20 | 2004-06-01 | Cornell Res Foundation Inc | Methods and compositions for treating or preventing skin disorders using binding agents specific for prostate-specific membrane antigen |
| US7087206B2 (en) * | 2002-04-12 | 2006-08-08 | Pg Research Foundation | Multicolumn selectivity inversion generator for production of high purity actinium for use in therapeutic nuclear medicine |
| US7651689B2 (en) * | 2002-11-15 | 2010-01-26 | Albert Einstein College Of Medicine Of Yeshiva University | Methods of applying ionization radiation for therapy of infections |
| WO2004062722A2 (en) * | 2003-01-08 | 2004-07-29 | Sloan Kettering Institute For Cancer Research | Prevention of systemic toxicity during radioimmunotherapy for intravascularly disseminated cancers |
| ES2314272T3 (es) | 2003-01-10 | 2009-03-16 | Millennium Pharmaceuticals, Inc. | Metodos para el diagnostico y el tratamiento del cancer. |
| US7820787B2 (en) | 2003-01-23 | 2010-10-26 | The Regents Of The University Of California | Multi-functional antibodies |
| US7528235B2 (en) | 2003-01-23 | 2009-05-05 | The Regents Of The Univarsity Of California | Multi-functional antibodies |
| US7402385B2 (en) | 2003-02-11 | 2008-07-22 | Albert Einstein College Of Medicine Of Yeshiva University | Radiolabeled antibodies for treatment of tumors |
| US6900507B1 (en) * | 2004-01-07 | 2005-05-31 | Micron Technology, Inc. | Apparatus with silicide on conductive structures |
| US20050247330A1 (en) * | 2004-04-30 | 2005-11-10 | Hp Intellectual Corp. | Liquid presence sensor |
| US7618627B2 (en) | 2004-06-03 | 2009-11-17 | The Regents Of The University Of California | Method of increasing radiation sensitivity by inhibition of beta one integrin |
| US20060018827A1 (en) * | 2004-07-08 | 2006-01-26 | Ekaterina Dadachova | Positron therapy of inflammation, infection and disease |
| AU2008302345A1 (en) * | 2007-09-19 | 2009-03-26 | Oncofluor, Inc. | Method for imaging and treating organs and tissues |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4831122A (en) * | 1986-01-09 | 1989-05-16 | Regents Of The University Of Minnesota | Radioimmunotoxins |
| CA2100709C (en) * | 1992-07-27 | 2004-03-16 | Maurits W. Geerlings | Method and means for site directed therapy |
| US5843894A (en) * | 1995-03-21 | 1998-12-01 | Center For Molecular Medicine And Immunology | Methods for reduced renal uptake of antibody fragments |
| US5580838A (en) * | 1995-06-05 | 1996-12-03 | Patterson; James A. | Uniformly plated microsphere catalyst |
| JPH11507046A (ja) * | 1995-06-07 | 1999-06-22 | イムノメディクス,インコーポレイテッド | 診断剤および治療剤の標的部位への改良された送達方法 |
| WO1998035707A1 (en) * | 1997-02-18 | 1998-08-20 | Thomas Jefferson University | Compositions that bind to pancreatic cancer cells and methods of using the same |
-
2000
- 2000-06-07 AU AU57270/00A patent/AU5727000A/en not_active Abandoned
- 2000-06-07 CA CA002374001A patent/CA2374001A1/en not_active Abandoned
- 2000-06-07 EP EP00942678A patent/EP1187637A2/en not_active Withdrawn
- 2000-06-07 JP JP2001501263A patent/JP2004510683A/ja active Pending
- 2000-06-07 US US09/588,565 patent/US6667024B1/en not_active Expired - Lifetime
- 2000-06-07 WO PCT/US2000/015477 patent/WO2000074729A2/en not_active Ceased
-
2003
- 2003-12-01 US US10/724,397 patent/US7220399B2/en not_active Expired - Fee Related
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CY2020003I2 (el) | Anti-il-12 αντισωματα, συνθεσεις, μεθοδοι και χρησεις για την θεραπευτικη αγωγη της παθολογιας του crohn | |
| CY2019029I2 (el) | Anti-tnf αντισωματα, συνθεσεις, μεθοδοi και χρησεις | |
| CY2010011I2 (el) | Μορια αντισωματος που εμφανιζουν ειδικοτητα για ανθρωπινο παραγοντα νεκρωσης ογκων α, και χρηση αυτων | |
| DE60142342D1 (de) | Antikörper gegen doppelintegrinen, zusammensetzungen, verfahren und verwendungen | |
| FR13C0068I2 (fr) | Conjugues du maytansinoide dm1 avec l'anticorps trastuzumab, attache par une liaison non-clivable, et son utilisation dans le traitement des tumeurs. | |
| CY2014038I1 (el) | Αντι-il-6 αντισωματα, συνθεσεις, μεθοδοι και χρησεις | |
| NO20035108L (no) | Cytotoksiske CD44-antistoff-immunokonjugater | |
| DE60142500D1 (de) | Humane monoklonale Antikörper gegen das kostimulatorische Signaltransduktionsmolekül AILIM und pharmazeutische Verwendungen davon | |
| CY2012003I2 (el) | Αντισωματα που συνδεονται ανοσοειδικως προς blys | |
| JP2002531090A5 (cg-RX-API-DMAC7.html) | ||
| ATE409047T1 (de) | Humanisierte antikörper | |
| DE60138118D1 (de) | Spiralabtastrekonstruktion des herzens für tomograph mit zweidimensionaler detektoranordung | |
| ATE464374T1 (de) | Assay zum schnellen nachweis vom humanen aktivierten protein c und hochspezifischer monoklonaler antikörper dagegen | |
| GB0008305D0 (en) | Treatment of fungal infections | |
| DE3482905D1 (de) | Monoklonale antikoerper gegen lungenkrebs des "nicht-kleine-zellen"-typs. | |
| DE69530078D1 (de) | Antigen/antikörper spezifitätsaustauscher | |
| DE60126482D1 (de) | Einkettige antikörper gegen eine p53 mutante | |
| WO2000074729A3 (en) | Alpha or beta emitters to fragments in radioimmunotherapy | |
| DK1411962T3 (da) | Terapi for pancreacancer med monoklonalt stof | |
| EP1227159A4 (en) | MONOCLONAL ANTIBODY, HYBRIDOMA, IMMUNITY TEST AND DIAGNOSTIC KIT | |
| ATE457318T1 (de) | Gegen das menschliche bst2 antigen gerichteter monoklonaler antikörper | |
| TR200103432T2 (tr) | Engelleyici monoklonal VLA-1 antikoru ve enflamasyonlu hastalıkların tedavisinde kullanımı. | |
| WO2004003155A3 (en) | Humanized anti-tag-72 cc49 for diagnosis and therapy of human tumors | |
| DE69115104D1 (de) | Composition comprising at least two different antibodies or fragments thereof. | |
| IS6143A (is) | Peptíð úr TT veiruröð og einsérhæfð mótefni, sem bindast TT veirunni |